Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing

UK to announce funding boost for life sciences


The UK government is trying to placate the disgruntled life sciences industry by investing in mining health data and increasing the domestic manufacturing of vaccines and drugs. 
Ministers are expected on Friday to unveil more than £150mn of funding for the UK Biobank, a pioneering genomics project, to quadruple its research capacity to advance scientists’ and drugmakers’ understanding of human biology.
Cows in a field in County Donegal, Ireland
The industry has also raised concerns about a drop in clinical trials conducted in the NHS in the past five years, arguing the UK is not making the most of the single health system that should make it easier to do research.
This story originally appeared on: Financial Times - Author:Hannah Kuchler